期刊文献+

药物支架与普通支架对PCI术围手术期高敏CRP的影响

Comparison of Effects of Drug-Eluting Stents(DES) Versus Bare Metal Stents(BMS) on Serum High-sensitive C-Reactive Protein Levels in Patients with Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的:对比观察药物支架(DES)与普通支架(BMS)对PCI患者高敏C反应蛋白水平(Hs-CRP)的影响,探讨经皮冠状动脉介入治疗(PCI)术后再狭窄的发生机制。方法:置入了单个支架的冠心病稳定性心绞痛患者83例入选本研究,DES组43例,BMS组40例,另选同期住院行冠脉造影检查显示冠状动脉不同程度的狭窄,而未行PCI的冠心病患者35例做对照组,分别于术前和术后48、72 h和2周测定血清Hs-CRP。结果:术前三组患者临床特征及冠脉造影显示的病变特征相似,具有可比性,术前及术后2周血清Hs-CRP水平组间无显著差别,术后48、72 hPCI患者较对照组Hs-CRP水平显著升高[48 h(13.42±14.70)mg/L比(5.89±4.93)mg/L,P<0.01;72 h(16.67±19.81)mg/L比(5.38±3.94)mg/L,P<0.01],但DES组与BMS组比较升高幅度小[48 h(6.26±4.36)mg/L比(21.02±15.46)mg/L,P<0.01;72 h(4.83±3.50)mg/L比(15.03±9.79)mg/L,P<0.01)。结论:PCI可显著升高Hs-CRP水平,但DES与BMS相比,可明显降低Hs-CRP水平,表明DES可明显抑制PCI术后诱发的急性炎症反应,继而抑制血管平滑肌细胞的增殖和迁移,可能是其预防PCI术后再狭窄的机制之一。 Objective :To compare the effect of DES and BMS stenting on the levels of serum High-sensitive C reactive protein (Hs-CRP) and to investigate the mechanism of restenosis after coronary stenting. Methods,, 83 patients with stable angina underwent with single stent, 35 patients coronary artery stenosis exceeding 70~ did not recveive PCI for various kinds of reason, all patients were enrolled in this study. Serum Hs-CRP levels were determined before inter- vention and at 48 hours, 72 hours, as well as 2 weeks after coronary stenting. Result..There was no difference in clinical and angiographic baseline characteristics in patients. After PCI or CAG serum Hs-CRP levels were significantly higher in the stent implantation group than in the CAG group at 48 hoursE(13. 42±14. 70) mg/L vs (5.89±4.93) mg/L,P〈 0.01land 72 hoursE(16.67±19. 81) mg/L vs (5.38±3.94) mg/L,P〈0.01];moreover, after stent implantation Hs- CRP levels were significantly lower in the DES group than in the BMS group at 48 hoursE(6. 26±4. 36) mg/L vs (21.02 ±15.46) mg/L,P〈0. 01] and 72 hours [(4. 83±3. 50) mg/L vs (15.03±9.79) mg/L,P〈0.01]. Conclusions:DESs show significantly lower serum Hs-CRP levels after coronary stenting compared with BMSs. This may reflect the potent effects of DESs on acute inflammatory reactions induced by coronary intervention.
出处 《中国误诊学杂志》 CAS 2008年第1期1-3,共3页 Chinese Journal of Misdiagnostics
关键词 支架 血管成形术 经腔 经皮冠状动脉 C反应蛋白质/代谢 冠状动脉再狭窄/预防和控制 人类 Stents Angioplasty, Transluminal, Percutaneous Coronary C-Reactive Protein/metabolism CoronaryRestenosis/prevention control Human
  • 相关文献

参考文献8

  • 1Wilson SH,Berger PB,Mathew V,et al.Immediate and late outcomes after direct stent implantation without balloon predilatation[J].J Am Coll Cardiol,2000,35(4):937-943.
  • 2沈青山,刘永胜,朱锐,付度关,汤永谦,陶红,李素珍,叶剑文.氟伐他汀干预治疗对不稳定性心绞痛患者介入治疗后炎症因子影响的研究[J].中华心血管病杂志,2005,33(4):320-322. 被引量:26
  • 3Farb A,Sangiorgi G,Carter AJ,et al.Pathology of acute and chronic coronary stenting in humans[J].Circulation,1999,99(1):44-52.
  • 4LI JJ,Fang CH.C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease[J].Med Hypotheses,2004,62(4):499-506.
  • 5Gaspardone A,Crea F,Versaci F,et al.Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina[J].Am J Cardiol,1998,82(4):515-518.
  • 6徐广马,林英忠,王风,袁军,刘伶,伍广伟.阿托伐他汀对冠状动脉介入术后C反应蛋白的影响[J].临床心血管病杂志,2005,21(8):488-489. 被引量:8
  • 7Bhatia V,Bhatia R,Dhindsa M.Drugeluting stents:new era and new concerns[J].Postgrad Med J,2004,80(939):13-18.
  • 8Dela Torre-Hernandez JM,Sainz-Laso F,Burgos V,et al.Comparison of C-reactive protein levels after coronary stenting with bare metal versus sirolimus-eluting stents[J].Am J Cardiol,2005,95(6):748-751.

二级参考文献14

  • 1Prevention of cardiovascular events and death with Pravastatin in patients with coronary heart disease and a broad rang of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. N Engl J Med, 1998,339: 1349-1357.
  • 2Serruys PW, de Feyter P, Macaya C, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.JAMA, 2002 ,287:3215-3222.
  • 3Ruygrok PN, de Jaegere PT, van Domburg RT, et al. Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients. J Am Coll Cardiol, 1996,27: 1669-1677.
  • 4Wilson SH, Berger PB, Mathew V, et al. Immediate and late outcomes after direct stent implantation without ballon predilation. J Am Coll Cardiol, 2000, 35: 937-943.
  • 5Ravkilde J, Nissen H, Mickley H, et al. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J, 1994,127: 13-20.
  • 6Harrington RA. Cardiac enzyme elevation after percutaneous coronary intervention:myonecrosis, the coronary microcirculation and mortality. J Am Coll Cardiol, 2000,35: 1142-1144.
  • 7Serruys PW, Foley DP, Jackson G, et al.A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary ballon angioplasty: final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J, 1999,20: 58-69.
  • 8Mulder HJ, Bal ET, Jukema JW, et al. Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial). Am J Cardiol, 2000,86: 742-746.
  • 9Gaspardone A,Crea F,Versaci F,et al.Predictive vaiue of C-reactive protein after successful coronary-artery stenting in patients with stable angina.Am J Cardiol,1998,82:515-518.
  • 10Pieterma A,Kofflard M,Dewitl E,et al.Late human loss after Coronary angioplasty is associated with the activation status of circulating,phagocytes before treatment.Circulation,1995,91:1320-1325.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部